|Titre :||Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution|
|Titre traduit :||(Estimations des usagers par injection et de leur distribution par sexe et par âge, aux niveaux national et local dans des pays en développement et en transition)|
|Auteurs :||C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN|
|Type de document :||Périodique|
|Année de publication :||2006|
|Format :||iii10-iii17 + tabl. / tabl.|
|Note générale :||
Sexually Trasmitted Infections, 2006, 82, (Suppl.III), iii10-iii17 + tabl.
Erratum in: Sex Transm Infect. 2006 Aug;82(4):344.
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASEDEVELOPPEMENT ; EVALUATION ; ETUDE PROSPECTIVE ; INJECTION ; PREVALENCE ; SEXE ; AGE ; PRODUIT ILLICITE
Thésaurus GéographiqueEUROPE DE L'EST ; INTERNATIONAL ; ASIE ; AFRIQUE ; AMERIQUE DU SUD
OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature review of both grey and published literature including updates from previously reported estimates on estimates of IDU population and data sources giving age and gender breakdowns. The scope area was developing/transitional countries and the reference period was 1998-2005. RESULTS: Estimates of IDU numbers were available in 105 countries and 243 subnational areas. The largest IDU populations were reported from Brazil, China, India, and Russia (0.8 m, 1.9 m, 1.1 m, and 1.6 m respectively). Subnational areas with the largest IDU populations (35,000-79,000) are: Warsaw (Poland); Barnadul, Irtkustk, Nizhny-Novgorod, Penza, Voronez, St Petersburg, and Volgograd (Russia); New Delhi and Mumbai (India); Jakarta (Indonesia), and Bangkok (Thailand). By region, Eastern Europe and Central Asia have the largest IDU prevalence (median 0.65%) (min 0.3%; max 2.2%; Q1 0.39%; Q3 1.32%) [corrected] followed by Asia and Pacific: 0.24% (min 0.004%; max 1.47%; Q1 0.14%; Q3 1.47%) [corrected] In the Middle East and Africa the median value equals 0.2% (min 0.0003%; max 0.35%; Q1 0.11%; Q3 0.23%) [corrected] and in Latin America and the Caribbean: 0.12% (min 0.11%; max 0.69%; Q1 0.04%; Q3 0.13%) [corrected] Subnational areas with the highest IDU prevalence among adults (8-14.9%) were Shymkent (Kazakhstan), Balti (Moldova), Astrakhan, Barnadul, Irtkustk, Khabarovsk, Kaliningrad, Naberezhnyje Chelny, Penza, Togliatti, Volgograd, Voronez, and Yaroslavl (Russia), Dushanbe (Tajikistan), Ashgabad (Turkmenistan), Ivano-Frankivsk and Pavlograd (Ukraine) and Imphal, Manipur (India). 66% (297/447) of the IDU estimates were reported without technical information. Data on the IDU age/gender distributions are also scarce or unavailable for many countries. In 11 Eastern European and Central Asian countries the age group 50% of the total. The proportion of IDU men was 70%-90% in Eastern Europe and Central Asia, and there was a marked absence of data on women outside this region. CONCLUSION: Unfortunately data on IDU prevalence available to national and international policymakers is of an unknown and probably yet to be tested quality. This study provide baseline figures but steps need to be taken now to improve the reporting and assessment of these critical data.
|Note de contenu :||tabl.|
|Domaine :||Drogues illicites / Illicit drugs|
|Sous-type de document :||Revue de la littérature / Literature review|
|Refs biblio. :||42|
Department of Public Health and Policy, Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT. Email : Carmen.Aceijas@lshtm.ac.uk
Royaume-Uni. United Kingdom.
|Numéro Toxibase :||1301832|
|Centre Emetteur :||13 OFDT|